Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Daiichi Sankyo
Daiichi Sankyo
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
I-Mab Biopharma US Limited
Merus B.V.
Pfizer
Pfizer
Syndax Pharmaceuticals
IMGT Co., Ltd.
Amgen
Genfleet Therapeutics (Shanghai) Inc.
Alligator Bioscience AB
Incyte Corporation
MacroGenics
DEKA Biosciences
Sirtex Medical
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Bristol-Myers Squibb
BioLineRx, Ltd.
Persephone Biosciences
Celldex Therapeutics
Amgen
Silenseed Ltd
Sinocelltech Ltd.
Concordia Laboratories Inc.
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Boston Scientific Corporation
MyGenostics Inc., Beijing
Ningbo Cancer Hospital
Shenzhen Hornetcorn Bio-technology Company, LTD
Shenzhen Hornetcorn Bio-technology Company, LTD
Hoffmann-La Roche
Pharmexa A/S
Light Sciences LLC
Light Sciences LLC
FeRx